Identification of peptides from human pathogens able to cross-activate an HIV-1-gag-specific CD4+ T cell clone

European Journal of Immunology

Volumn 36, Issue 1, 2006, Pages 27-36

  Venturini, Sara ^a,d   Allicotti, Gina ^b   Zhao, Yindong ^c   Simon, Richard ^c   Burton, Dennis R ^a   Pinilla, Clemencia ^b   Poignard, Pascal ^a,e  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e INSERM   (France)

Author keywords

Combinatorial libraries; Cross reactivity; Epitope specificity; HIV; T cells

Indexed keywords

CD4 ANTIGEN; GAG PROTEIN; PEPTIDE; PEPTIDE LIBRARY; VIRUS PROTEIN;

ARTICLE; BIOMETRY; CELL SPECIFICITY; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SERODIAGNOSIS; T LYMPHOCYTE;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CLONE CELLS; CROSS REACTIONS; GENE PRODUCTS, GAG; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; VIRAL PROTEINS;

EID: 30944444376     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425767     Document Type: Article

References (41)

1. Macatonia, S. E., Patterson, S. and Knight, S. C., Primary proliferative and cytotoxic T-cell responses to HIV induced in vitro by human dendritic cells. Immunology 1991. 74: 399-406.
2. Vyakarnam, A., Matear, P. M., Cranenburg, C., Michie, C., Beverley, P. C., Wahren, B., Gill, S. K. and Weller, I., T cell responses to peptides covering the gag p24 region of HIV-1 occur in HIV-1 seronegative individuals. Int. Immunol. 1991. 3: 939-947.
3. Bedford, P. A., Clarke, L. B., Hastings, G. Z. and Knight, S. C., Primary proliferative responses to peptides of HIV Gag p24. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1997. 14: 301-306.
4. + cell depletion. Cell 1988. 54: 561-575.
5. Manca, F., Habeshaw, J. and Dalgleish, A., The naive repertoire of human T helper cells specific for gp120, the envelope glycoprotein of HIV. J. Immunol. 1991. 146: 1964-1971.
6. Martin, S. J., Vyakarnam, A., Cheingsong-Popov, R., Callow, D., Jones, K. L., Senior, J. M., Adams, S. E. et al., Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses. Aids 1993. 7: 1315-1323.
7. Venturini, S., Mosier, D. E., Burton, D. R. and Poignard, P., Characterization of human immunodeficiency virus type 1 (HIV-1) Gag- and Gag peptide-specific CD4(+) T-cell clones from an HIV-1-seronegative donor following in vitro immunization. J. Virol. 2002. 76: 6987-6999.
8. Hemmer, B., Vergelli, M., Pinilla, C., Houghten, R. and Martin, R., Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol. Today 1998. 19: 163-168.
9. Ignatowicz, L., Rees, W., Pacholczyk, R., Ignatowicz, H., Kushnir, E., Kappler, J. and Marrack, P., T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. Immunity 1997. 7: 179-186.
10. Sparbier, K. and Walden, P., T cell receptor specificity and mimotopes. Curr. Opin. Immunol. 1999. 11: 214-218.
11. Mason, D., Avery high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 1998. 19: 395-404.
12. Selin, L. K., Nahill, S. R. and Welsh, R. M., Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J. Exp. Med. 1994. 179: 1933-1943.
13. Selin, L. K., Varga, S. M., Wong, I. C. and Welsh, R. M., Protective heterologous antiviral immunity and enhanced immunopathogenesis mediated by memory T cell populations. J. Exp. Med. 1998. 188: 1705-1715.
14. Selin, L. K., Lin, M. Y., Kraemer, K. A., Pardoll, D. M., Schneck, J. P., Varga, S. M., Santolucito, P. A. et al., Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 1999. 11: 733-742.
15. + T cells in heterologous antiviral immunity and immunopathology in the lung. Nat. Immunol. 2001. 2: 1067-1076.
16. Zhao, Y., Gran, B., Pinilla, C., Markovic-Plese, S., Hemmer, B., Tzou, A., Whitney, L. W. et al., Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J. Immunol. 2001. 167: 2130-2141.
17. Borras, E., Martin, R., Judkowski, V., Shukaliak, J., Zhao, Y., Rubio-Godoy, V., Valmori, D. et al., Findings on T cell specificity revealed by synthetic combinatorial libraries. J. Immunol. Methods 2002. 267: 79-97.
18. Nino-Vasquez, J. J., Allicotti, G., Borras, E., Wilson, D. B., Valmori, D., Simon, R., Martin, R. and Pinilla, C., A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol. Immunol. 2004. 40: 1063-1074.
19. Hemmer, B., Vergelli, M., Gran, B., Ling, N., Conlon, P., Pinilla, C., Houghten, R. et al., Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J. Immunol. 1998. 160: 3631-3636.
20. Pinilla, C., Martin, R., Gran, B., Appel, J. R., Boggiano, C., Wilson, D. B. and Houghten, R. A., Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr. Opin. Immunol. 1999. 11: 193-202.
21. Hemmer, B., Pinilla, C., Appel, J., Pascal, J., Houghten, R. and Martin, R., The use of soluble synthetic peptide combinatorial libraries to determine antigen recognition of T cells. J. Pept. Res. 1998. 52: 338-345.
22. Hemmer, B., Gran, B., Zhao, Y., Marques, A., Pascal, J., Tzou, A., Kondo, T. et al., Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 1999. 5: 1375-1382.
23. Rubio-Godoy, V., Dutoit, V., Zhao, Y., Simon, R., Guillaume, P., Houghten, R., Romero, P. et al., Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J. Immunol. 2002. 169: 5696-5707.
24. Marsh, S. G. E., Parham, P. and Barber, L. D., The HLA Facts Book. Academic Press, San Diego 2000
25. Coenye, T., Vandamme, P., Govan, J. R. and LiPuma, J. J., Taxonomy and identification of the Burkholderia cepacia complex. J. Clin. Microbiol. 2001. 39: 3427-3436.
26. Henry, D. A., Mahenthiralingam, E., Vandamme, P., Coenye, T. and SpeeM D. P., Phenotypic methods for determining genomovar status of the Burkholderia cepacia complex. J. Clin. Microbiol. 2001. 39: 1073-1078.
27. De Baere, T., Steyaert, S., Wauters, G., Des Vos, P., Goris, J., Coenye, T., Suyama, T. et al., Classification of Ralstonia pickettii biovar 3/'thomasii' strains (Pickett 1994) and of new isolates related to nosocomial recurrent meningitis as Ralstonia mannitolytica sp. nov. Int. J. Syst. Evol. Microbiol. 2001. 51: 547-558.
28. Olsen, R. H., Kukor, J. J. and Kaphammer, B., A novel toluene-3-monooxygenase pathway cloned from Pseudomonas pickettii PKO1. J. Bacteriol. 1994. 176: 3749-3756.
29. LiPuma, J. J., Spilker, T., Coenye, T. and Gonzalez, C. F., An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 2002. 359: 2002-2003.
30. Yoneyama, A., Yano, H., Hitomi, S., Okuzumi, K., Suzuki, R. and Kimura, S., Ralstonia pickettii colonization of patients in an obstetric ward caused by a contaminated irrigation system. J. Hosp. Infect. 2000. 46: 79-80.
31. Holmes, A., Nolan, R., Taylor, R., Finley, R., Riley, M., Jiang, R. Z., Steinbach, S. and Goldstein, R., An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J. Infect. Dis. 1999. 179: 1197-1205.
32. Maroye, P., Doermann, H. P., Rogues, A. M., Gachie, J. P. and Megraud, F., Investigation of an outbreak of Ralstonia pickettii in a paediatric hospital by RAPD. J. Hosp. Infect. 2000. 44: 267-272.
33. Coenye, T. and LiPuma, J. J., Molecular epidemiology of burkholderia species. Front. Biosci. 2003. 8: E55-67.
34. Coenye, T., Vandamme, P. and LiPuma, J. J., Infection by Ralstonia species in cystic fibrosis patients: identification of R. pickettii and R. mannitolilytica by polymerase chain reaction. Emerg. Infect. Dis. 2002. 8: 692-696.
35. Haussler, S., Lehmann, C., Breselge, C., Rohde, M., Classen, M., Tummler, B., Vandamme, P. and Steinmetz, I., Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur. J. Clin. Microbiol. Infect. Dis. 2003. 22: 249-253.
36. De Soyza, A., McDowell, A., Archer, L., Dark, J. H., Elborn, S. J., Mahenthiralingam, E., Gould, K. and Corris, P. A., Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet 2001. 358: 1780-1781.
37. Watts, C., Antigen processing in the endocytic compartment. Curr. Opin. Immunol. 2001. 13: 26-31.
38. Watts, C., Moss, C. X., Mazzeo, D., West, M. A., Matthews, S. P., Li, D. N. and Manoury, B., Creation versus destruction of T cell epitopes in the class II MHC pathway. Ann. NY Acad. Sci. 2003. 987: 9-14.
39. + T cells. Nature 2002. 417: 95-98.
40. Houghten, R. A., General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc. Natl. Acad. Sci. USA 1985. 82: 5131-5135.
41. Pinilla, C., Appel, J. R. and Houghten, R. A., Investigation of antigen-antibody interactions using a soluble, non-support-bound synthetic decapeptide library composed of four trillion (4 × 10(12) sequences. Biochem. J. 1994. 301(Pt 3): 847-853.